CONTINENTAL ADVISORS LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 206 filers reported holding MYRIAD GENETICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
CONTINENTAL ADVISORS LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q2 2022$452,000
-27.9%
24,8920.0%0.27%
-11.7%
Q1 2022$627,000
-8.7%
24,8920.0%0.31%
+6.9%
Q4 2021$687,000
-14.6%
24,8920.0%0.29%
-15.2%
Q3 2021$804,000
-10.6%
24,892
-15.3%
0.34%
-17.6%
Q2 2021$899,000
+0.4%
29,3920.0%0.41%
-0.2%
Q1 2021$895,000
+24.3%
29,392
-19.2%
0.42%
+26.1%
Q4 2020$720,000
+51.6%
36,3920.0%0.33%
+30.6%
Q3 2020$475,000
+200.6%
36,392
+162.0%
0.25%
+196.5%
Q2 2020$158,000
-20.6%
13,8920.0%0.08%
-42.6%
Q1 2020$199,000
-47.4%
13,8920.0%0.15%
-19.1%
Q4 2019$378,000
-5.0%
13,8920.0%0.18%
-22.1%
Q3 2019$398,000
+3.1%
13,8920.0%0.24%
+7.8%
Q2 2019$386,000
-16.3%
13,8920.0%0.22%
+1.9%
Q1 2019$461,000
-39.0%
13,892
-46.6%
0.21%
-7.4%
Q4 2018$756,000
-36.8%
26,0000.0%0.23%
-11.5%
Q3 2018$1,196,000
+23.0%
26,0000.0%0.26%
+7.9%
Q2 2018$972,000
+26.6%
26,0000.0%0.24%
+24.1%
Q1 2018$768,000
-14.0%
26,0000.0%0.20%
+1.0%
Q4 2017$893,000
-29.9%
26,000
-26.1%
0.19%
-33.7%
Q3 2017$1,274,000
-18.0%
35,200
-41.4%
0.29%
-17.1%
Q2 2017$1,553,000
+34.6%
60,1000.0%0.35%
+36.0%
Q1 2017$1,154,000
+15.2%
60,1000.0%0.26%
-5.1%
Q4 2016$1,002,000
+51.6%
60,100
+87.2%
0.27%
+47.0%
Q3 2016$661,00032,1000.18%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders